Zdrowie i gospodarka · 03/02/2006

FDA Releases Draft Guidance on Patient-Reported Outcome Measures for Medical Product Development

The US Food and Drug Administration (FDA) has published a draft guidance document outlining how patient-reported outcome measures (PROs) can be used in medical product development to support labeling claims, aiming to improve the efficiency of the review process and provide more accurate information about product effectiveness.